Fundraising FoxBallantyne Therapeutics
Charlotte, US · Founded 2014 · Delaware corporation
Find your way into Ballantyne Therapeutics
Sign up to see every warm intro you have to Ballantyne Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ballantyne Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MR
Michael RobertsExecutive
Board
BE
Brian E. DoxtatorBoard director
DR
Donald R ReynoldsBoard director
SP
Simon PedderBoard director
Reported raises · per SEC filings
Form D private placements$565K disclosed across 1 round · 2015
▶$565KraisedOct 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$565KraisedOct 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brian E. DoxtatorDirector
- Michael RobertsExecutive Officer, Director
- Donald R ReynoldsDirector
- Simon PedderDirector
- Offering amount
- $800K
- Amount sold
- $565K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ballantyne Therapeutics raised?
- Ballantyne Therapeutics has disclosed $565K raised across 1 round.
- Where is Ballantyne Therapeutics headquartered?
- Ballantyne Therapeutics is headquartered in Charlotte, US.